Takahiro Kageyama

Takahiro Kageyama

Auto-generated profile, based on publicly available information

Takahiro Kageyama

Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Seminars in Immunopathology
Verified
Journal Article
Open access
PDF file
TKTakahiro Kageyama
Takahiro Kageyama
TITakashi Ito
Takashi Ito
STShigeru Tanaka
Shigeru Tanaka
HNHiroshi Nakajima
Hiroshi Nakajima
The lungs serve as the primary organ for respiration, facilitating the vital exchange of gases with the bloodstream. Given their perpetual exposure to external particulates and pathogens, they possess intricate protective barriers. Cellular adhesion in the lungs is robustly maintained through tight junctions, adherens junctions, and desmosomes. Furthermore, the pulmonary system features a mucociliary clearance mechanism that synthesizes mucus and transports it to the outside. This mucus is enriched with chemical barriers like antimicrobial proteins and immunoglobulin A (IgA). Additionally, a complex immunological network comprising epithelial cells, neural cells, and immune cells plays a pivotal role in pulmonary defense. A comprehensive understanding of these protective systems offers valuable insights into potential pathologies and their therapeutic interventions.

5 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HFHiroki Furuya
Hiroki Furuya
YTYosuke Toda
Yosuke Toda
AIArifumi Iwata
Arifumi Iwata
MKMizuki Kanai
Mizuki Kanai
KKKodai Kato
Kodai Kato
HNHiroshi Nakajima
Hiroshi Nakajima
Group 2 innate lymphoid cells (ILC2s) are a subset of innate lymphocytes that produce type 2 cytokines, including IL-4, IL-5, and IL-13. GATA3 is a critical transcription factor for ILC2 development at multiple stages. However, when and how GATA3 is induced to the levels required for ILC2 development remains unclear. Herein, we identify ILC2-specific GATA3-related tandem super-enhancers (G3SE) that induce high GATA3 in ILC2-committed precursors. G3SE-deficient mice exhibit ILC2 deficiency in the bone marrow, lung, liver, and small intestine with minimal impact on other ILC lineages or Th2 cells. Single-cell RNA-sequencing and subsequent flow cytometry analysis show that GATA3 induction mechanism, which is required for entering the ILC2 stage, is lost in IL-17RB+PD-1− late ILC2-committed precursor stage in G3SE-deficient mice. Cnot6l, part of the CCR4-NOT deadenylase complex, is a possible GATA3 target during ILC2 development. Our findings implicate a stage-specific regulatory mechanism for GATA3 expression during ILC2 development.

22 May 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
KSKensuke Suga
Kensuke Suga
ASAkira Suto
Akira Suto
STShigeru Tanaka
Shigeru Tanaka
YSYutaka Sugawara
Yutaka Sugawara
TKTakahiro Kageyama
Takahiro Kageyama
HNHiroshi Nakajima
Hiroshi Nakajima
Methotrexate (MTX) is a standard, first-line therapy for rheumatoid arthritis (RA); however, its precise mechanisms of action other than antifolate activity are largely unknown. We performed DNA microarray analyses of CD4 + T cells in patients with RA before and after MTX treatment and found that TP63 was the most significantly downregulated gene after MTX treatment. TAp63, an isoform of TP63, was highly expressed in human IL-17–producing Th (Th17) cells and was suppressed by MTX in vitro. Murine TAp63 was expressed at high levels in Th cells and at lower levels in thymus-derived Treg cells. Importantly, TAp63 knockdown in murine Th17 cells ameliorated the adoptive transfer arthritis model. RNA-Seq analyses of human Th17 cells overexpressing TAp63 and those with TAp63 knockdown identified FOXP3 as a possible TAp63 target gene. TAp63 knockdown in CD4 + T cells cultured under Th17 conditions with low-dose IL-6 increased Foxp3 expression, suggesting that TAp63 balances Th17 cells and Treg cells. Mechanistically, TAp63 knockdown in murine induced Treg (iTreg) cells promoted hypomethylation of conserved noncoding sequence 2 (CNS2) of the Foxp3 gene and enhanced the suppressive function of iTreg cells. Reporter analyses revealed that TAp63 suppressed the activation of the Foxp3 CNS2 enhancer. Collectively, TAp63 suppresses Foxp3 expression and exacerbates autoimmune arthritis.

2 November 2022 in Journal of Infection
Verified
Journal Article
Closed access
YMYoichi Mashimo
Yoichi Mashimo
KYKeiko Yamazaki
Keiko Yamazaki
TKTakahiro Kageyama
Takahiro Kageyama
STShigeru Tanaka
Shigeru Tanaka
TTToshibumi Taniguchi
Toshibumi Taniguchi
YOYoshihiro Onouchi
Yoshihiro Onouchi

1 June 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KSKazumasa Suzuki
Kazumasa Suzuki
KSKOTARO SUZUKI
KOTARO SUZUKI
YYYoko Yabe
Yoko Yabe
KIKazuma Iida
Kazuma Iida
JIJunichi Ishikawa
Junichi Ishikawa
HNHiroshi Nakajima
Hiroshi Nakajima

20 June 2023 in Allergology International
Verified
Journal Article
Open access
KSKensuke Suga
Kensuke Suga
MKMasahiro Kiuchi
Masahiro Kiuchi
TKTakahiro Kageyama
Takahiro Kageyama
KKKota Kokubo
Kota Kokubo
STShigeru Tanaka
Shigeru Tanaka
HNHiroshi Nakajima
Hiroshi Nakajima